Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men
Results of the phase 2 MALE clinical trial comparing 3 treatment regimens in men with hormone-receptor positive breast cancer are reported.
Breast Cancer
Cancer Diagnoses Increase at Age 65, Decrease Immediately Afterward
The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.
Benefit Seen With Ribociclib in Most Breast Cancer Subtypes
A team of investigators conducted a retrospective study to determine the relationship of intrinsic breast cancer subtypes on survival in patients undergoing endocrine therapy plus ribociclib.
Unplanned Implant Removal Following Treatment for Locally Advanced Breast Cancer
A team of investigators assessed the frequency and timing of unplanned breast implant removal in patients undergoing with mastectomy, reconstruction, and postmastectomy radiation therapy for locally advanced breast cancer.
Effects of Treatment, Inactivity on Arm Tissue Composition in Survivors of Breast Cancer
Results of an assessment of tissue composition changes experienced by breast cancer survivors without lymphedema are presented.
Adjuvant Abemaciclib Plus Endocrine Therapy Maintains Patient-Reported Outcomes in Early Breast Cancer
Results from the phase 3 monarchE trial on the addition of abemaciclib to endocrine therapy in patients with early breast cancer were presented at the 17th St. Gillen International Breast Cancer Conference.
Upfront Niraparib Showed Antitumor Activity in BRCA-Mutated Breast Cancer
A team of investigators sought to evaluate safety, tolerability, and antitumor activity neoadjuvant niraparib for patients with localized breast cancer.
MRI Yields Most Concordant Breast Cancer Tumor Size Assessment
A team of investigators sought to identify the most accurate preoperative breast imaging technique for determining tumor size in individuals with early breast cancer.
Breast Cancer Screening Improves Survival in Women With BRCA1/2 Mutations
A team of researches sought to assess the effectiveness of breast cancer surveillance among patients with BRCA1/2 mutations.
Strategy for Assessing Axillary Adenopathy on Mammography Following COVID-19 Vaccination
A team of radiologists explain their strategy for maintaining breast cancer screening in women with managing a potential side effect of vaccination.
- Loading...
Loading...
Next post in Breast Cancer
Loading... 
Loading...